ERN1 and Hyperglycemia: Kinase domain-specific inhibitor of IRE1α shows therapeutic potential in conditions like retinal degeneration and hyperglycemia by protecting photoreceptors and pancreatic β cells (Cross et al., 2012; Guirao-Abad et al., 2020).